CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy and research. Whether it’s your morning commute to work, a walk in the park, or just relaxing at home, the CAPhO Connections Podcast will offer a convenient way to keep up to date with all things oncology pharmacy!
CAPhO Connections Podcast
Claim This Podcastby Canadian Association of Pharmacy in Oncology
4.7(3 reviews)
30 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇨🇦
21
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality15
Social0
YouTube0
Engagement68
Podcast Overview
CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy and research. Whether it’s your morning commute to work, a walk in the park, or just relaxing at home, the CAPhO Connections Podcast will offer a convenient way to keep up to date with all things oncology pharmacy!
Language
🇺🇲
Publishing Since
5/25/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
21
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality15
Social0
YouTube0
Engagement68
5
Excellent Areas
1
Good Performance
13
Growth Opportunities
excellent
Episode Length
12 minutes
Performing excellently!
good
Episode GUID Consistency
60%
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 51 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for CAPhO Connections Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 28, 2026
CAPhO Connections Podcast: Brain Matters: Targeting IDH Mutant Low Grade Gliomas with Vorasidenib
<p>Step into the future of neuro-oncology with Vorasidenib, the first-in-class targeted therapy for dual IDH-mutant gliomas. In this episode, an oncology Nurse Practitioner and neurology Clinician-Investigator share their real-world experience, tracing Vorasidenib’s journey from early SAP use to Health Canada approval and its transformative impact on low-grade glioma management.</p><p><br></p><p>We explore key findings from the INDIGO trial, practical prescribing considerations, drug access, interaction management, toxicity monitoring, and how interprofessional teams optimize care across all age groups. Discover how this breakthrough therapy is reshaping glioma treatment, redefining pharmacy practice, and empowering pharmacists to drive better patient outcomes and quality of life.</p><p><br></p><p>Learning Objectives:</p><ul><li>Discuss key findings from the INDIGO trial, including clinical implications and touch upon future potential uses</li><li>Provide real-world experience and implications with vorasidenib at all stages from drug access, prescribing, monitoring, dispensing, tolerability, drug-interactions, follow up, and collaboration with care teams to optimize patient outcomes</li><li>Explore strategies to preserve neurocognitive function and quality of life for glioma patients receiving long-term vorasidenib treatment, including approaches to monitoring cognitive health, managing symptoms, and supporting patients’ functional well-being throughout therapy</li><li>Reflect on the role of oncology pharmacists in managing oral targeted therapies such as vorasidenib, and how pharmacists can work with other disciplines for effective care</li></ul><p><br></p><p>The Canadian Drug Agency (CDA) has recommended Voranigo(r) (vorasidenib) for reimbursement by provinces according to the criteria found <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2F%2Fwww.cda-amc.ca%2Fsites%2Fdefault%2Ffiles%2FDRR%2F2025%2FPC0407-Voranigo_Recommendation.pdf__%3B!!CjcC7IQ!JXN9UtcrttRV42WNLXMUAs6WI8poOfPKZT10zHdBeU31n72fp1jCKSwJcZ0PnOMiL_jhTR9gBxKR9uKMnnea-BZb%24&data=05%7C02%7Caidan.fay%40wearemci.com%7C8c762a9a858d41c6307508debcb33ce3%7Cac144e41800148f09e1c170716ed06b6%7C0%7C0%7C639155675473664286%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=iJitVPf9o1iIfhG93VtMMPxCyZIk7ZL81KCYrUTpYUo%3D&reserved=0" target="_blank" rel="noopener noreferer">here</a>. Since the recording of this episode, the province of Ontario has began funding vorasidenib under the Ontario Drug Benefit Exceptional Access Program, with the anticipation that other Canadian health ministries will follow. </p><p><br></p><p>About the Presenters:</p><p><strong>Andrea Wong</strong></p><p>Andrea graduated with a Bachelor of Science in Nursing from the University of Windsor in 2016, with her primary focus in oncology. She began her career at Sunnybrook Health Sciences Centre in 2016, working on the inpatient Medical and Radiation Oncology unit before transitioning to the Complex Malignant Hematology unit in 2018. In 2019, she obtained her Canadian Nurses Association (CNA) certification in Oncology Nursing.</p><p>Andrea went on to complete her Master of Nursing and Primary Health Care Nurse Practitioner Certificate at Toronto Metropolitan University in 2022. Since then, she has worked as a Nurse Practitioner in the Neuro-oncology Clinic at the Odette Cancer Centre, where her recent focus has been on the development and implementation of the vorasidenib program at Sunnybrook.</p><p>Andrea is a member of the Canadian Association of Nurses in Oncology and serves as an Adjunct Lecturer at the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto.</p><p><br></p><p><strong>Dr. James Perry</strong></p><p>Dr. James Perry is a Toronto-based clinical investigator and professor of neurology specializing in innovative therapies for primary brain tumours. He leads outcomes focused research for the Canadian brain tumour consortium, and has been the PI of several practice-changing clinical trials including new standards of care using metronomic temozolomide, chemoradiation in the eldery with glioblastoma, and recently the INDIGO study of vorasidenib for low grade glioma.</p><p><br></p>
March 20, 2026
CAPhO Connections Podcast Sponsored Episode - Honouring Excellence and Advancing Knowledge: HOPE Awards and the ABC Course
<p>CAPhO has made every effort to ensure that information included within this podcast episode is accurate at the time of production. The information cannot substitute for the advice or direction of a health care professional, and the association makes no guarantees, nor can it assume any legal liability for the accuracy, completeness, or usefulness of such information or for any damage incurred directly or indirectly from the information.</p><p>This episode of the CAPhO Connections Podcast is sponsored by Apobiologix.</p><p><br></p><p>Go behind the scenes with two steering committee members to highlight the HOPE Awards and the ABC course, two key initiatives sponsored by the Apobiologix Partnership Program. They'll share an insider's perspective on celebrating six years of excellence and building the foundational skills needed to advance oncology pharmacy practice across Canada.</p><p><br></p><p>Learning Objectives:</p><ol><li>Gain insights from steering committee members on the vision and impact of fostering professional development within Canadian oncology pharmacy, through the Apobiologix Partnership Program (APP).</li><li>Explore the purpose and evolution of the HOPE Awards through the personal experiences of the committee members and understand its role in celebrating excellence and innovation among pharmacists, technicians, and DANs.</li><li>Identify the unmet need for standardized oncology education among Canadian pharmacists and explain how the Addressing Basics in Cancer (ABC) program serves as a direct solution by providing essential, practical training.</li><li>Outline the key steps and criteria for participating in both the HOPE Awards and the ABC course, empowering listeners to engage with these valuable initiatives.</li></ol><p><br></p><p>Guests:</p><p><strong>Tina Crosbie</strong></p><p>Tina Crosbie is a clinical hematology pharmacist at The Ottawa Hospital’s ambulatory hematology unit. With over 25 years of experience, she counsels patients diagnosed with lymphoma, multiple myeloma, and acute and chronic leukemia. For the past six years, Tina is also a hematology pharmacist at Extend Pharmacy; a community oncology-focused pharmacy. Here she supports patients in managing their take-home anti-cancer therapy. Tina’s research aims to optimize drug administration and enhance patient education. She evaluates pharmacy education programs for CCCEP and is a conference planning committee member for CAPhO Con 2026 taking place April 2026 in Saskatoon, Saskatchewan.</p><p><br></p><p><strong>Scott Edwards</strong></p><p>Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.</p><p><br></p><p>Learn more about the<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fhope-awards.com%2F&data=05%7C02%7Caidan.fay%40wearemci.com%7C11d1d9959e154118863c08de6e80e648%7Cac144e41800148f09e1c170716ed06b6%7C0%7C0%7C639069697069757506%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=DUxo5E%2BfycfHoUYspucJRD13gFW%2FMOOVT4w1%2Fdgx%2BLY%3D&reserved=0" target="_blank" rel="noopener noreferer"> HOPE Awards</a>.</p><p>Learn more about the <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.abcprogram.ca%2F&data=05%7C02%7Caidan.fay%40wearemci.com%7C11d1d9959e154118863c08de6e80e648%7Cac144e41800148f09e1c170716ed06b6%7C0%7C0%7C639069697069739331%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=o5biTTy8bKZz1uwTzQmQyGJ8ocB%2F%2Fo4wYCFN%2BYIAvrM%3D&reserved=0" target="_blank" rel="noopener noreferer">ABC Program</a>.</p>
March 13, 2026
CAPhO Connections Podcast: Cracking the Code: Pharmacists in the Age of Precision Oncology
<p>Precision oncology is advancing cancer care, turning one-size-fits-all treatment into tailored therapy designed for each patient’s unique genetic blueprint. For oncology pharmacists, this opens new possibilities to lead in matching the right drug, dose, and patient at the right time. In this episode, we explore how pharmacists can decode the genomic puzzle, navigate biomarker-driven decisions, and drive innovation in personalized cancer care. Get ready to discover why precision pharmacy isn’t just the future, it is happening now!</p><p><br></p><p>Learning Objectives:</p><ul><li>Describe the evolving role of oncology pharmacists in biomarker-guided therapy and precision oncology decision-making.</li><li>Identify pharmacy-led innovations in personalized cancer care and their application in diverse practice settings.</li><li>Evaluate strategies to integrate genomic and biomarker data into pharmacy workflows while managing operational challenges.</li><li>Assess the impact of precision oncology on outcomes, safety, and resource use, highlighting the pharmacist’s role.</li><li>Outline practical steps for pharmacists to lead precision oncology initiatives through collaboration, education, and research.</li></ul><p><br></p><p>Guest: Dr. Mya Tran</p><p>Dr. Mya Tran, PharmD, BCOP, is a Precision Oncology Clinical Pharmacist at Indiana University Health Simon Comprehensive Cancer Center. Since joining the IU Precision Genomics program in 2022, she specializes in genomic analysis and targeted therapies for solid tumors, particularly lung cancer, while standardizing biomarker testing protocols</p><p><br></p><p>Resources Referenced:</p><p>- Podcasts: Research to Practice, Onc Brothers, Illumina Genomics Podcast</p><p>- Virtual MTBs:</p><ul><li>Caris (https://www.carislifesciences.com/caris-resources/caris-molecular-tumor-board/ or email Ricci Sheridan at RSheridan@carisls.com)</li><li>NCCN (https://education.nccn.org/tumorboards#group-tabs-node-course-default1)</li></ul><p>- GenomeWeb (webinars, resources, and archived vMTBs)</p><p>- Targeted Oncology</p><p>- Precision Oncology News newsletter</p><p>- ACCP/HOPA PGx Certificate Course</p><p>- Harvard HMX Pro Genetics - Cancer Genomics and Precision Oncology Certificate Course</p><p>- AMP (especially webinars and "Molecular in My Pocket" reference cards)</p>
30 total episodes available
Deep-dive analytics for CAPhO Connections Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is CAPhO Connections Podcast?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.